Lenabasum Showing Promise in Systemic Scleroderma Lenabasum Showing Promise in Systemic Scleroderma

The oral, synthetic, nonimmunosuppressive small molecule improves outcome scores for patients with few treatment options, new research shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news